DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Nitz U, Gluz O, Christgen M. et al.
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Breast Cancer Res Treat 2017;
DOI: 10.1007/s10549-017-4358-6.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.